IL7 and neoplasm: Previous studies showed that IL-7 can support immune-cell reconstitution in lymphopenic conditions [22–25], restore sepsis-induced lymphocyte dysfunctions ([37, 38]), enhance effector function of autoreactive T cells [8–13], and expand tumor-reactive T cells [29, 30].